The end of the second quarter has seen corporate venturing units involved in consortia investing more than $4.8bn round the world in 280 deals.
The majority (193) of the deals were in the US, according to Global Corporate Venturing. The top 10 deals represented more than $1.5bn of the total, including money raised to return to existing shareholders, as with the $400m LivingSocial round for the Amazon-backed discount coupon provider. (Click for link to full table.)
By stage, there was a fairly even split at between 30 and 40 deals between series A, B and C rounds, although 87 were undisclosed. Technology deals dominated by sector, with clean-tech having 45 deals while information technology had 65; healthcare (47) and media (34) followed.
On exits, portfolio companies raised more than $2bn from flotations, led by social network RenRen and chip company Fusion-io. The venture capital figures have yet to be released but overall the quarter saw at least 720 companies file with regulators to list on stock exchanges and $56bn raised by all parties, despite the MSCI World index falling 3% in the past three month.
Corporate venturing units were part of consortia which will reap at least $3.9bn from 20 announced trade sales, with another nine deals of undisclosed value, according to Global Corporate Venturing.
The biggest agreed sales in the three months between April and end-June were Advanced BioHealing for $750m, Clearwell for $410m and AdMeld for $400m.
Global merger and acquisitions volume fell 17.5% to $516.1bn in the second quarter, according to Mergermarket reported by its parent the Financial Times.